Patricia A Egner Selected Research

Aflatoxin B1 (Aflatoxin B)

1/2020	Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case-control study.
1/2019	Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution.
1/2017	Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence.
8/2015	Dietary aflatoxin-induced stunting in a novel rat model: evidence for toxin-induced liver injury and hepatic growth hormone resistance.
3/2015	Prenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change.
8/2012	A single neonatal exposure to aflatoxin b1 induces prolonged genetic damage in two loci of mouse liver.
7/2011	Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.
1/2010	Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1.
5/2009	Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.
9/2006	Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia A Egner Research Topics

Disease

12	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2003
11	Neoplasms (Cancer) 01/2021 - 09/2006
10	Liver Neoplasms (Liver Cancer) 01/2021 - 08/2002
8	Carcinogenesis 01/2013 - 02/2006
6	Growth Disorders 01/2021 - 08/2015
4	Infections 01/2017 - 08/2002
3	Chronic Disease (Chronic Diseases) 01/2018 - 10/2008
3	Inflammation (Inflammations) 04/2012 - 02/2006
2	Hepatitis B 09/2003 - 02/2003
1	Gallstones (Gallstone) 01/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Hepatitis 01/2017
1	Squamous Cell Carcinoma of Head and Neck 07/2016
1	Mouth Neoplasms (Oral Cancer) 07/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2015
1	Persistent Infection 10/2013
1	Leukemia 08/2008
1	Aflatoxin Poisoning 03/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2006
1	Body Weight (Weight, Body) 02/2006

Drug/Important Bio-Agent (IBA)

25	AflatoxinsIBA 01/2021 - 08/2002
12	Aflatoxin B1 (Aflatoxin B)IBA 01/2020 - 02/2003
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2003
5	DNA AdductsIBA 01/2017 - 02/2003
4	CarcinogensIBA 01/2021 - 05/2009
3	TriterpenesIBA 07/2014 - 02/2006
3	oltiprazIBA 05/2009 - 08/2002
3	chlorophyllin (copper chlorophyll)IBA 11/2004 - 08/2002
2	MycotoxinsIBA 01/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2012
2	AlbuminsIBA 01/2018 - 03/2008
2	IsothiocyanatesIBA 01/2018 - 10/2008
2	sulforaphaneIBA 07/2016 - 01/2013
2	MutagensIBA 03/2015 - 07/2011
2	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 07/2014 - 02/2006
2	Proteins (Proteins, Gene)FDA Link 05/2009 - 08/2008
2	EnzymesIBA 08/2008 - 07/2005
2	ChlorophyllIBA 06/2007 - 02/2003
2	Oxidoreductases (Dehydrogenase)IBA 09/2006 - 07/2005
1	Coloring Agents (Dyes)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	ORALIT (ORS)IBA 01/2020
1	GlucosinolatesIBA 01/2018
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 07/2016
1	Growth Hormone (Somatotropin)IBA 08/2015
1	Oxidants (Oxidizing Agents)IBA 01/2013
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2012
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2011
1	GuanineIBA 05/2011
1	A-Form DNA (A-DNA)IBA 05/2011
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2010
1	AntioxidantsIBA 05/2009
1	Schiff Bases (Schiff Base)IBA 05/2009
1	AKR7A1IBA 05/2009
1	Glutathione (Reduced Glutathione)IBA 10/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008
1	TBE 31IBA 08/2008
1	AcidsIBA 03/2008
1	Lysine (L-Lysine)FDA Link 03/2008
1	NADP (NADPH)IBA 09/2006
1	AminesIBA 08/2006
1	3-ethylanilineIBA 08/2006
1	imidazoleIBA 02/2006
1	Oleanolic AcidIBA 02/2006
1	phenanthreneIBA 11/2005
1	HydrocarbonsIBA 11/2005
1	NAD (NADH)IBA 07/2005
1	quinone (benzoquinone)IBA 07/2005

Therapy/Procedure

4	Chemoprevention 08/2008 - 08/2002
1	Plant-Based Diet 04/2012
1	Drug Therapy (Chemotherapy) 08/2008